Want to create an interactive transcript for this episode?
Podcast: Psychedelics Today
Episode: PT469 – Mason Marks, MD, JD – Drug Policy in 2023: The FDA's Guidance for Clinical Trials, The Natural Medicine Act, and SB-303
Description: In this episode, Joe interviews Mason Marks, MD, JD: drug policy analyst, writer, Professor at the Florida State University College of Law, and senior fellow and project lead of the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. As somewhat of an expert on drug policy and FDA regulation, Marks discusses much of the current legal landscape: What was controversial and most interesting about the FDA's recent guidance for researchers running clinical trials; how an amendment changed Colorado's Natural Medicine Act and the odd vibe coming from...